Derivation Web

source_992dcf0286c14130

{"contradictions": ["The current evidence supports telomere length as a reproducible prognostic marker for cancer recurrence and diabetes complications, but its value as a therapeutic target remains unproven; interventions that lengthen telomeres have not yet demonstrated downstream clinical benefit, and mechanistic plausibility alone is insufficient to justify routine clinical application.", "23 …